Growing community of inventors

Täby, Sweden

Styrbjörn Byström

Average Co-Inventor Count = 3.10

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 2

Styrbjörn ByströmJan Vågberg (8 patents)Styrbjörn ByströmElisabeth Olsson (5 patents)Styrbjörn ByströmArthur Glenn Romero (2 patents)Styrbjörn ByströmMattias Jönsson (2 patents)Styrbjörn ByströmHåkan Mellstedt (2 patents)Styrbjörn ByströmJiong Jack Chen (2 patents)Styrbjörn ByströmEvert Homan (1 patent)Styrbjörn ByströmJessica Martinsson (1 patent)Styrbjörn ByströmKatarina Färnegårdh (2 patents)Styrbjörn ByströmCharles Hedgecock (1 patent)Styrbjörn ByströmCharlotta Liljebris (1 patent)Styrbjörn ByströmThomas Lundback (1 patent)Styrbjörn ByströmMeral Sari (1 patent)Styrbjörn ByströmNinus Caram-Lelham (1 patent)Styrbjörn ByströmThomas LUNDBÄCK (0 patent)Styrbjörn ByströmStyrbjörn Byström (12 patents)Jan VågbergJan Vågberg (13 patents)Elisabeth OlssonElisabeth Olsson (6 patents)Arthur Glenn RomeroArthur Glenn Romero (38 patents)Mattias JönssonMattias Jönsson (5 patents)Håkan MellstedtHåkan Mellstedt (4 patents)Jiong Jack ChenJiong Jack Chen (3 patents)Evert HomanEvert Homan (10 patents)Jessica MartinssonJessica Martinsson (3 patents)Katarina FärnegårdhKatarina Färnegårdh (2 patents)Charles HedgecockCharles Hedgecock (2 patents)Charlotta LiljebrisCharlotta Liljebris (2 patents)Thomas LundbackThomas Lundback (1 patent)Meral SariMeral Sari (1 patent)Ninus Caram-LelhamNinus Caram-Lelham (1 patent)Thomas LUNDBÄCKThomas LUNDBÄCK (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Kancera Ab (9 from 15 patents)

2. Pharmacia & Upjohn Company (2 from 523 patents)

3. Aprea Ab (1 from 6 patents)


12 patents:

1. 12264165 - Process for the stereoselective preparation of chiral 2-[(hetero) arylalkylsulfanyl]pyrimidines and products obtainable therefrom

2. 12060380 - Phosphate and phosphonate derivatives of 7-amino-5-thio-thiazolo[4,5-d]pyrimidines and their use in treating conditions associated with elevated levels of CX3CR1 and/or CX3CL1

3. 11691988 - Process for the stereoselective preparation of chiral 2-[(hetero)arylalkylsulfanyl]pyrimidines and products obtainable therefrom

4. 11660303 - 2-phenylimidazo[4,5-b]pyridin-7-amine derivates useful as inhibitors of mammalian tyrosine kinase ROR1 activity

5. 11542281 - Process for the steroselective preparation of chiral 2- [(hetero)arylalkylsulfanyl] pyrimidines and products obtainable therefrom

6. 11339183 - Phosphate and phosphonate derivatives of 7-amino-5-thio-thiazolo[4,5-d]pyrimidines and their use in treating conditions associated with elevated levels of CX3CR1 and/or CX3CL1

7. 11008318 - 2-phenylimidazo[4,5-b]pyridin-7-amine derivates useful as inhibitors of mammalian tyrosine kinase ROR1 activity

8. 10550113 - 2-phenyl-3H-imidazo[4,5-B]pyridine derivates useful as inhibitors of mammalian tyrosine kinase ROR1 activity

9. 9233946 - Sulfonamide compounds

10. 9061016 - Aqueous solution comprising 3-quinuclidinones for the treatment hyperproliferative, autoimmune and heart disease

11. 6576769 - Process to prepare (2S)-2-(dipropylamino)-6-ethoxy-2,3-dihydro-1H-indene-5-carboxamide

12. 6462234 - Process to prepare (2S)-2-(dipropylamino)-6-ethoxy-2, 3-dihydro-1H-indene-5-carboxamide

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/3/2025
Loading…